BioMedica产品目录

BioMedica产品目录

 

BioMedica Diagnostics是符合ISO 13485:2016标准的GMP检测设施。专注于在,人类和动物健康领域提供定制的,价格合理的诊断解决方案。

BioMedica产品目录

ACTICHROME® AT III activity assay

Category: Coagulation

Tag: Specialty Coagulation Reagents

 

ACTICHROME® Heparin (anti-FIIa) assay

Category: Coagulation

Tag: Specialty Coagulation Reagents

 

ACTICHROME® Heparin (anti-FXa) assay

Category: Coagulation

Tag: Specialty Coagulation Reagents

 

ACTICHROME® PLG activity assay

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

ACTICHROME® TF activity assay

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

ACTICHROME® TFPI activity assay

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

ACTICLOT® C, Protein C activity assay

Category: Coagulation

Tag: Specialty Coagulation Reagents

 

ACTICLOT® dPT™, dilute Prothrombin Time test

Category: Coagulation

Tag: Specialty Coagulation Reagents

 

ACTICLOT® Protein C Resistance

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

ACTICLOT® Protein C Resistance, Control Plasmas

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

ACTICLOT® Protein S activity assay

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

ACTIFLUOR™ ADAMTS13 Activity Assay (Outside U.S.A.)

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

ACTIFLUOR™ ADAMTS13 Activity Assay (U.S.A.)

Category: Coagulation
Tag: Research Products

 

ActiScreen™ XL-FDP Latex Agglutination

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

Alpha-Thrombin, human

Category: Coagulation
Tag: Research Products

 

Antithrombin III Deficient Human Plasma

Category: Coagulation
Tag: Research Products

 

Aprotinin

Category: Coagulation
Tag: Research Products

 

DIMERTEST® Latex Kit

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

DVVconfirm®

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

DVVtest®

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

Factor IXa, human, beta sub-unit

Category: Coagulation
Tag: Research Products

 

Factor Va, human

Category: Coagulation
Tag: Research Products

 

Factor VIII deficient human plasma

Category: Coagulation
Tag: Research Products

 

Factor X, human

Category: Coagulation
Tag: Research Products

 

Factor Xa, human, RVV activated

Category: Coagulation
Tag: Research Products

 

Factor XIa, human

Category: Coagulation
Tag: Research Products/

Factor XIIa (activated Hageman Factor)

Category: Coagulation
Tag: Research Products

 

FEMTELLE™ uPA/PAI-1 ELISA (Outside U.S.A.)

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

glu-Plasminogen, human

Category: Coagulation
Tag: Research Products

Goat anti-human Tissue Factor IgG

Category: Coagulation
Tag: Research Products

 

Human glu-plasminogen

Category: Coagulation
Tag: Research Products

 

IMUBIND® ADAMTS13 Autoantibody ELISA (Outside U.S.A.)

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUBIND® ADAMTS13 Autoantibody ELISA (U.S.A.)

Category: Coagulation
Tag: Research Products

IMUBIND® ADAMTS13 ELISA (Outside U.S.A.)

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUBIND® ADAMTS13 ELISA (U.S.A.)

Category: Coagulation
Tag: Research Products

 

IMUBIND® FVIIa ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUBIND® Plasma PAI-1 ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUBIND® Thrombomodulin ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUBIND® Tissue Factor ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUBIND® Tissue PAI-1 ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUBIND® uPA ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUBIND® vWF Activity ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUBIND® vWF ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUCLONE™ Alpha-2-Antiplasmin ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUCLONE™ D-dimer ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUCLONE™ FPA (Fibrinopeptide A) ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUCLONE™ Free Protein S ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

IMUCLONE™ Platelet Factor 4 ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents/

IMUCLONE™ TAFI ELISA

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

Kallikrein, human

Category: Coagulation
Tag: Research Products

 

LAtrol™ LA Abnormal Control Plasma

Category: Coagulation
Tag: Specialty Coagulation Reagents

LAtrol™ LA Normal Control Plasma

Category: Coagulation
Tag: Specialty Coagulation Reagents/

Murine MAb against fibrin neotope beta-chain IgG

Category: Coagulation
Tag: Research Products

 

Murine MAb against Gla (gamma-carboxyglutamyl) amino acid

Category: Coagulation
Tag: Research Products

 

Murine MAb against human factor VIII-CAg, IgG2a

Category: Coagulation
Tag: Research Products

 

Murine MAb against human fVIIa

Category: Coagulation
Tag: Research Products

 

Murine MAb against human Growth Hormone Receptor

Category: Coagulation
Tag: Research Products

 

Murine MAb against human PAI-1, IgG1

Category: Coagulation
Tag: Research Products

 

Murine MAb against human Tissue Factor

Category: Coagulation
Tag: Research Products

 

Murine MAb against human Tissue Factor, aa 1-25

Category: Coagulation
Tag: Research Products

Murine MAb against human tissue factor, FITC conjugated

Category: Coagulation
Tag: Research Products

 

Murine MAb against human tissue factor, FITC conjugated

Category: Coagulation
Tag: Research Products

 

Plasmin, human

Category: Coagulation
Tag: Research Products

 

Plasminogen activator, u-PAU

Category: Coagulation
Tag: Research Products

Plasminogen, bovine

Category: Coagulation
Tag: Research Products

 

Protac®, direct protein C activator

Category: Coagulation
Tag: Research Products

 

QuikCoag APTT-EA

Category: Bleeding Profiles

Tag: Research Products

 

QuikCoag APTT-S

Category: Bleeding Profiles

 

QuikCoag Calcium Chloride 0.020M

Category: Bleeding Profiles

 

QuikCoag Control

Category: Bleeding Profiles

 

QuikCoag Fibrinogen

Category: Bleeding Profiles

 

QuikCoag Fibrinogen Kit

Category: Bleeding Profiles

 

QuikCoag Imidazole Buffer

Category: Bleeding Profiles

 

QuikCoag Multi Parameter Controls

Category: Bleeding Profiles

 

QuikCoag PT-HS

Category: Bleeding Profiles

 

Rabbit anti-mouse tissue factor IgG

Category: Coagulation
Tag: Research Products

 

Recombinant factor VIIa, human

Category: Coagulation
Tag: Research Products

 

Recombinant human Tissue Factor

Category: Coagulation
Tag: Research Products

 

Recombinant Thrombomodulin, human

Category: Coagulation
Tag: Research Products

SPECTROFLUOR™ FIXa

Category: Coagulation
Tag: Research Products

 

SPECTROFLUOR™ FXa

Category: Coagulation
Tag: Research Products

 

SPECTROLYSE® PAI-1 Activity Assay

Category: Coagulation
Tag: Specialty Coagulation Reagents

 

SPECTROZYME® FIXa

Category: Coagulation
Tag: Research Products

 

SPECTROZYME® FXa

Category: Coagulation
Tag: Research Products

 

SPECTROZYME® LAL

Category: Coagulation
Tag: Research Products

 

SPECTROZYME® PCa

Category: Coagulation
Tag: Research Products

 

SPECTROZYME® PL

Category: Coagulation
Tag: Research Products

 

SPECTROZYME® TH

Category: Coagulation
Tag: Research Products

 

SPECTROZYME® tPA

Category: Coagulation
Tag: Research Products

 

TFPI Depleted Plasma

Category: Coagulation
Tag: Research Products

 

Thrombomodulin, rabbit lung

Category: Coagulation
Tag: Research Products

 

tPA/PAI Depleted Plasma, human

Category: Coagulation
Tag: Research Products

 

von Willebrand Factor (vWF), human, fVIII free

Category: Coagulation
Tag: Research Products

 

biomedicadiagnostics中国代理, biomedicadiagnostics上海代理, biomedicadiagnostics北京代理,biomedicadiagnostics广东代理, biomedicadiagnostics江苏代理biomedicadiagnostics湖北代理,biomedicadiagnostics天津代理, biomedicadiagnostics黑龙江代理, biomedicadiagnostics内蒙古代理, biomedicadiagnostics吉林代理, biomedicadiagnostics福建代理,  biomedicadiagnostics江苏代理, biomedicadiagnostics浙江代理,  biomedicadiagnostics四川代理,

 

上海金畔生物科技有限公司是实验试剂一站式采购服务商

1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。

2:产品种类齐全,经营超过700多品牌,基本涵盖所有生物实验试剂耗材。

3:提供加急服务,货品一般1-2周到货。

4:富有竞争良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等知药企。

6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司代理。

7:我们还是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等知*批发,欢迎合作。

 

BioMedica

 

BioMedica Diagnostics 238L

BioMedica Diagnostics 238L

 

BioMedica Diagnostics是一家自豪的加拿大公司,专注于为人类和动物健康领域提供定制的经济实惠的诊断解决方案。

BioMedica Diagnostics 238L 说明书

SAFETY DATA SHEET

SECTION 1: Identification of the substance/mixture and of the company/undertaking

1.1. Product identifier

 

Trade name or designation of the mixture

Registration number Synonyms

Product code Issue date Version number

SPECTROZYME® TH 50 umole

 

None.     

238L

01-December-2017

02

 

Revision date 11-July-2017

Supersedes date 14-July-2015

1.2. Relevant identified uses of the substance or mixture and uses advised against

 

Identified uses

Uses advised against

Research use only.

Use in accordance with supplier's recommendations.

SECTION 2: Hazards identification

2.1. Classification of the substance or mixture

The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.

Classification according to Regulation (EC) 272/2008 as amended

Health hazards

 

Skin corrosion/irritation

Serious eye damage/eye irritation

 

Specific target organ toxicity – single exposure

Category 2

Category 2

 

Category 3 respiratory tract irritation

H315 – Causes skin irritation.

H319 – Causes serious eye irritation.

H335 – May cause respiratory irritation.

 

Hazard summary Irritating to eyes, respiratory system and skin.

2.2. Label elements

Label according to Regulation (EC) 272/2008 as amended

Contains: H-D-cyclohexylalanyl-alanyl-arginine-para-nitroanilide diacetate saltt

Hazard pictograms

 

 

 

Signal word Warning

 

Hazard statements

H315 Causes skin irritation.

H319 Causes serious eye irritation.

H335 May cause respiratory irritation.

 

P261 Avoid breathing dust.

P264 Wash thoroughly after handling.

P271 Use only outdoors or in a well-ventilated area.

P280 Wear protective gloves.

P280 Wear eye/face protection.

Response

P302 + P352 IF ON SKIN: Wash with plenty of water.

P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

P312 Call a POISON CENTER/doctor if you feel unwell. P332 + P313 If skin irritation occurs: Get medical advice/attention. P337 + P313 If eye irritation persists: Get medical advice/attention.

P362 + P364 Take off contaminated clothing and wash it before reuse.

Storage

P403 + P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up.

Disposal

P501 Dispose of contents/container in accordance with local/regional/national/international regulations.

Supplemental label information None.

2.3. Other hazards Not a PBT or vPvB substance or mixture.

SECTION 3: Composition/information on ingredients

 

Chemical name

% CAS-No / EC

No

REACH Registration No

INDEX No

Notes

 

 

 

H-D-cyclohexylalanyl-alanyl-arginine- para-nitroanilide diacetate saltt

45 – 65

None

 

Classification: Skin Irrit. 2;H315, Eye Irrit. 2;H319, STOT SE 3;H335

 

 

Glycine

 

Classification:

20 – 40

56-40-6

200-272-2

 

Composition comments

All concentrations are in percent by weight unless ingredient is a gas. Gas concentrations are in percent by volume. The full text for all H-statements is displayed in section 16.

 

SECTION 4: First aid measures

 

General information

Ensure that medical personnel are aware of the material(s) involved, and take precautions to protect themselves. If you feel unwell, seek medical advice (show the label where possible).

 

4.1. Description of first aid measures

 

Inhalation Skin contact Eye contact

 

Ingestion

4.2. Most important symptoms and effects, both acute and delayed

4.3. Indication of any immediate medical attention and special treatment needed

Remove victim to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTRE or doctor/physician if you feel unwell.

Remove contaminated clothing. Wash with plenty of soap and water. If skin irritation occurs: Get medical advice/attention. Wash contaminated clothing before reuse.

Do not rub eyes. Immediay flush eyes with plenty of water for at least 15 minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Get medical attention if irritation develops and persists.

Rinse mouth. Get medical attention if symptoms occur.

May cause redness and pain. Symptoms of overexposure may be headache, dizziness, tiredness, nausea and vomiting.

 

Provide general supportive measures and treat symptomatically.

 

SECTION 5: Firefighting measures

 

General fire hazards

5.1. Extinguishing media Suitable extinguishing media

Unsuitable extinguishing media

5.2. Special hazards arising from the substance or mixture

5.3. Advice for firefighters Special protective equipment for firefighters

Special fire fighting procedures

No unusual fire or explosion hazards noted. Will burn if involved in a fire.

 

Water fog. Foam. Dry chemical powder. Carbon dioxide (CO2). Do not use water jet as an extinguisher, as this will spread the fire. During fire, gases hazardous to health may be formed.

 

Self-contained breathing apparatus and full protective clothing must be worn in case of fire. Use standard firefighting procedures and consider the hazards of other involved materials.

 

SECTION 6: Accidental release measures

6.1. Personal precautions, protective equipment and emergency procedures

 

For non-emergency personnel

 

 

For emergency responders

 

6.2. Environmental precautions

6.3. Methods and material for containment and cleaning up

 

 

 

 

 

6.4. Reference to other sections

Keep unnecessary personnel away. Keep people away from and upwind of spill/leak. Wear appropriate protective equipment and clothing during clean-up. Avoid inhalation of dust. Ensure adequate ventilation. Local authorities should be advised if significant spillages cannot be contained.

Keep unnecessary personnel away. Use personal protection recommended in section 8 of the SDS.

Avoid discharge into drains, water courses or onto the ground.

Avoid dispersal of dust in the air (i.e., clearing dust surfaces with compressed air). Collect dust using a vacuum cleaner equipped with HEPA filter. Stop the flow of material, if this is without risk.

 

Large Spills: Wet down with water and dike for later disposal. Shovel the material into waste container. Following product recovery, flush area with water.

 

Small Spills: Sweep up or vacuum up spillage and collect in suitable container for disposal. Clean surface thoroughly to remove residual contamination.

For personal protection, see section 8. For waste disposal, see section 13 of the SDS.

 

SECTION 7: Handling and storage

 

7.1. Precautions for safe handling

 

 

7.2. Conditions for safe storage, including any incompatibilities

7.3. Specific end use(s)

Minimise dust generation and accumulation. Provide appropriate exhaust ventilation at places where dust is formed. Avoid breathing dust. Avoid contact with eyes, skin, and clothing. Avoid prolonged exposure. Wear appropriate personal protective equipment. Observe good industrial hygiene practices.

Store locked up. Store in original tightly closed container. Store in a well-ventilated place. Store away from incompatible materials (see section 10 of the SDS).

 

Research use only.

 

SECTION 8: Exposure controls/personal protection

8.1. Control parameters

 

Occupational exposure limits Biological limit values

Recommended monitoring procedures

No exposure limits noted for ingredient(s).

No biological exposure limits noted for the ingredient(s). Follow standard monitoring procedures.

 

Derived no-effect level (DNEL) Not available.

 

Predicted no effect concentrations (PNECs)

8.2. Exposure controls

Not available.

 

Appropriate engineering controls

Good general ventilation (typically 10 air changes per hour) should be used. Ventilation rates should be matched to conditions. If applicable, use process enclosures, local exhaust ventilation, or other engineering controls to maintain airborne levels below recommended exposure limits. If exposure limits have not been established, maintain airborne levels to an acceptable level. If engineering measures are not sufficient to maintain concentrations of dust particulates below the OEL (occupational exposure limit), suitable respiratory protection must be worn. If material is ground, cut, or used in any operation which may generate dusts, use appropriate local exhaust ventilation to keep exposures below the recommended exposure limits. Eye wash facilities and emergency shower must be available when handling this product.

 

Individual protection measures, such as personal protective equipment

 

General information

 

 

Eye/face protection Skin protection

– Hand protection

 

– Other

Respiratory protection

 

Thermal hazards Hygiene measures

 

Environmental exposure controls

Use personal protective equipment as required. Personal protection equipment should be chosen according to the CEN standards and in discussion with the supplier of the personal protective equipment.

Wear safety goggles and a face shield.

 

Wear appropriate chemical resistant gloves. Suitable gloves can be recommended by the glove supplier.

Wear appropriate chemical resistant clothing.

In case of inadequate ventilation or risk of inhalation of dust or fumes, use suitable respiratory equipment.

Wear appropriate thermal protective clothing, when necessary.

Always observe good personal hygiene measures, such as washing after handling the material and before eating, drinking, and/or smoking. Routinely wash work clothing and protective equipment to remove contaminants.

Environmental manager must be informed of all major releases.

 

SECTION 9: Physical and chemical properties

9.1. Information on basic physical and chemical properties Appearance

 

Physical state Form

Colour Odour

Solid.

White powder.

White.

Not available.

 

Odour threshold Not available.

pH Not available.

Melting point/freezing point Not available.

 

Initial boiling point and boiling range

Not available.

 

Flash point Not available.

Evaporation rate Not available.

Flammability (solid, gas) Not available.

Upper/lower flammability or explosive limits

 

Flammability limit – lower (%)

Flammability limit – upper (%)

Not available.

 

Not available.

 

Vapour pressure Not available.

Vapour density Not available.

Relative density Not available.

Solubility(ies) Soluble in water.

 

Partition coefficient (n-octanol/water)

Not available.

 

Auto-ignition temperature Not available. Decomposition temperature Not available. Viscosity Not available.

 

Explosive properties Oxidizing properties

9.2. Other information

Not available.

Not available.

No relevant additional information available.

 

SECTION 10: Stability and reactivity

 

10.1. Reactivity

10.2. Chemical stability

10.3. Possibility of hazardous reactions

10.4. Conditions to avoid

10.5. Incompatible materials

10.6. Hazardous decomposition products

The product is stable and non-reactive under normal conditions of use, storage and transport. Material is stable under normal conditions.

Hazardous polymerisation does not occur.

 

Contact with incompatible materials. Strong oxidising agents. Strong acids. Carbon monoxide. Carbon dioxide.

 

SECTION 11: Toxicological information

General information Occupational exposure to the substance or mixture may cause adverse effects.

Information on likely routes of exposure

Inhalation Dust may irritate respiratory system. Prolonged inhalation may be harmful.

Skin contact Causes skin irritation.

Eye contact Causes serious eye irritation.

Ingestion May cause discomfort if swallowed.

Symptoms Symptoms of overexposure may be headache, dizziness, tiredness, nausea and vomiting. May cause redness and pain.

11.1. Information on toxicological effects

Acute toxicity May cause discomfort if swallowed.

 

Skin corrosion/irritation

Serious eye damage/eye irritation

Causes skin irritation. Causes serious eye irritation.

 

Respiratory sensitisation Not a respiratory sensitiser.

 

Skin sensitisation Germ cell mutagenicity

Not a skin sensitiser.

No data available to indicate product or any components present at greater than 0.1% are mutagenic or genotoxic.

 

Carcinogenicity Not classifiable as to carcinogenicity to humans.

 

Reproductive toxicity

Specific target organ toxicity – single exposure

Specific target organ toxicity – repeated exposure

This product is not expected to cause reproductive or developmental effects. May cause respiratory irritation.

 

Not classified.

 

Aspiration hazard Not classified.

 

Mixture versus substance information

Not available.

 

Other information No other specific acute or chronic health impact noted.

 

SECTION 12: Ecological information

12.1. Toxicity The product is not classified as environmentally hazardous. However, this does not exclude the possibility that large or frequent spills can have a harmful or damaging effect on the environment.

 

12.2. Persistence and degradability

12.3. Bioaccumulative potential

Partition coefficient

n-octanol/water (log Kow)

No data is available on the degradability of this product.

 

 

Not available.

 

Bioconcentration factor (BCF) Not available.

 

12.4. Mobility in soil

12.5. Results of PBT and vPvB assessment

No data available.

Not a PBT or vPvB substance or mixture.

 

12.6. Other adverse effects No other adverse environmental effects (e.g. ozone depletion, photochemical ozone creation potential, endocrine disruption, global warming potential) are expected from this component.

 

SECTION 13: Disposal considerations

13.1. Waste treatment methods

 

Residual waste

 

 

Contaminated packaging

 

 

EU waste code

 

Disposal methods/information

Dispose of in accordance with local regulations. Empty containers or liners may retain some product residues. This material and its container must be disposed of in a safe manner (see: Disposal instructions).

Empty containers should be taken to an approved waste handling site for recycling or disposal. Since emptied containers may retain product residue, follow label warnings even after container is emptied.

The Waste code should be assigned in discussion between the user, the producer and the waste disposal company.

Collect and reclaim or dispose in sealed containers at licensed waste disposal site. Dispose of contents/container in accordance with local/regional/national/international regulations.

 

SECTION 14: Transport information

ADR

Not regulated as dangerous goods.

RID

Not regulated as dangerous goods.

ADN

Not regulated as dangerous goods.

IATA

Not regulated as dangerous goods.

IMDG

Not regulated as dangerous goods.

 

14.7. Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code

Not applicable.

 

SECTION 15: Regulatory information

15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture EU regulations

Regulation (EC) 005/2009 on substances that deplete the ozone layer, Annex I and II, as amended

Not listed.

Regulation (EC) No 850/2004 On persistent organic pollutants, Annex I as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 1 as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 2 as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 3 as amended

Not listed.

Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex V as amended

Not listed.

Regulation (EC) No 166/2006 Annex II Pollutant Release and Transfer Registry, as amended

Not listed.

Regulation (EC) 907/2006, REACH Article 59(10) Candidate List as currently published by ECHA

Not listed.

Authorisations

Regulation (EC) 907/2006, REACH Annex XIV Substances subject to authorization, as amended

Not listed.

Restrictions on use

Regulation (EC) No1907/2006, REACH Annex XVII Substances subject to restriction on marketing and use as amended

Not listed.

Directive 2004/37/EC: on the protection of workers from the risks related to exposure to carcinogens and mutagens at work, as amended

Not listed.

Directive 92/85/EEC: on the safety and health of pregnant workers and workers who have recently given birth or are breastfeeding, as amended

Not listed.

Other EU regulations

Directive 2012/18/EU on major accident hazards involving dangerous substances

Not listed.

 

Directive 98/24/EC on the protection of the health and safety of workers from the risks related to chemical agents at work

Not listed.

Directive 94/33/EC on the protection of young people at work

Not listed.

 

Other regulations

 

 

 

 

National regulations

15.2. Chemical safety assessment

The product is classified and labelled in accordance with Regulation (EC) 1272/2008 (CLP Regulation) as amended and respective national laws implementing EC directives. This Safety Data Sheet complies with the requirements of Regulation (EC) 907/2006.

In the European Union this product is regulated under the In Vitro Diagnostic Medical Devices Directive (98/79/EC).

Follow national regulation for work with chemical agents. No Chemical Safety Assessment has been carried out.

 

SECTION 16: Other information

List of abbreviations

 

 

 

References

Information on evaluation method leading to the classification of mixture

Full text of any H-statements not written out in full under Sections 2 to 15

 

 

Training information Disclaimer

DNEL: Derived No-Effect Level.

PNEC: Predicted No-Effect Concentration.

IARC Monographs. Overall Evaluation of Carcinogenicity

The classification for health and environmental hazards is derived by a combination of calculation methods and test data, if available.

 

 

 

H315 Causes skin irritation.

H319 Causes serious eye irritation. H335 May cause respiratory irritation.

Follow training instructions when handling this material.

The information above is provided in good faith. It is believed to be accurate and represents the best information currently available to us. HOWEVER, WE MAKE NO WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR OF ANY OTHER TYPE, EXPRESSED OR IMPLIED, WITH RESPECT TO PRODUCTS DESCRIBED OR DATA OR INFORMATION PROVIDED, AND WE ASSUME NO LIABILITY RESULTING FROM THE USE OF

SUCH PRODUCTS, DATA OR INFORMATION. Users should make their own investigations to determine the suitability of the information for their particular purposes, and the user assumes all risk arising from their use of the material. The user is required to comply with all laws and regulations relating to the purchase, use, storage and disposal of the material, and must be familiar with and follow generally accepted safe handling procedures. In no event shall BioMedica Diagnostics be liable for any claims, losses, or damages of any individual or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if BioMedica Diagnostics has been advised of the possibility of such damages.

 

 

上海金畔生物科技有限公司是实验试剂一站式采购服务商

1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。

2:产品种类齐全,经营超过700多个品牌,基本涵盖所有生物实验试剂耗材。

3:提供加急服务,货品一般1-2周到货。

4:富有竞争力的价格优势,绝大部分价格有优势。

5:多年积累良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等药企。

6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司代理。

7:我们还是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等*批发,欢迎合作。

biomedica diagnostics代理

biomedica diagnostics代理-上海金畔生物

biomedica diagnostics创建于1999年,biomedica diagnostics在全球、人类和动物健康领域提供定制、经济实惠的诊断解决方案。biomedical diagnostics的产品和技术遍布70多个国家,通过与全球研究人员和从业者合作,将诊断产品和技术带到人类和动物健康医学研究的前沿,帮助推动医疗保健创新。

biomedica diagnostics主要提供以下领域的相关产品

抗凝治疗

血流分析

癌症预后

抗磷脂综合征

血管性血友病

D-二聚体

血栓风险标志物

血栓性血小板减少性紫癜

 

更多其它产品详情请查询biomedica diagnostics网站或咨询biomedica diagnostics中国代理上海金畔生物。

 

biomedica diagnostics热卖产品

货号

产品名称

规格

品牌

238L

SPECTROZYME® TH(金畔现货)

50 μmole

biomedica diagnostics

848RUO

ACTICHROME® TFPI

100 T

biomedica diagnostics

3570

Murine MAb against Gla (gamma-carboxyglutamyl) amino acid

0.5 mg

biomedica diagnostics

222L

SPECTROZYME® FXa

50 μmole

biomedica diagnostics

299

SPECTYROZYME® FIXa

10 µmole

biomedica diagnostics

449B

Factor IXa, human, beta sub-unit

500 μg

biomedica diagnostics

812RUO

Actifluor™ Adamts13 Activity Assay

96 T

biomedica diagnostics

470HT

Human alpha-thrombin

2500 Units

biomedica diagnostics

812

ACTIFLUR ADAMTS13 Activity

48 T

biomedica diagnostics

222F

SPECTROFLUOR™ FXa, fluorogenic substrate for FXa

10 μmole

biomedica diagnostics

222B

SPECTROZYME® FXa

0.5 g

biomedica diagnostics

814RUO

IMUBIND® ADAMTS13 Autoantibody ELISA

96T

biomedica diagnostics

816A

LAtrol™ Lupus Anticoagulant Abnormal Control Plasma

10 x 0.5 mL

biomedica diagnostics

816N

LAtrol™ Lupous Anticoagulant Normal Control Plasma

10 x 1.0 mL

biomedica diagnostics

824

ACTICLOT® dPT™

EA

biomedica diagnostics

C.BMD.FIBN-01ML-8A

Fibrinogen Control Normal

10 x 1.0 mL

biomedica diagnostics

C.BMD.FIBL-01ML-8A

Fibrinogen Control Low Abnormal

10 x 1.0 mL

biomedica diagnostics

作为biomedica diagnostics在中国区域的代理,上海金畔生物将为中国客户提供全面的biomedica diagnostics产品。欢迎大家随时联系我们!!!

Biomedica代理

Biomedica代理

简要描述:Biomedica代理,Biomedica上海代理,Biomedica北京代理,Biomedica代理,Biomedica一级代理,Biomedica代理
BioMedica Diagnostics Inc.是私有的加拿大医疗生物技术公司,目标是向世界新兴经济体提供产品。BioMedica创建于1999年,总部位于新斯高沙省温莎,专长为小型诊所和医院提供心血管诊断和价廉物美的医疗诊断解决方

详细介绍

产品咨询

Biomedica代理,Biomedica上海代理,Biomedica北京代理,Biomedica代理,Biomedica一级代理,Biomedica代理
上海金畔生物科技有限公司Biomedica专业代理,具体产品信息欢迎电询:021-50837765

BioMedica Diagnostics Inc.是私有的加拿大医疗生物技术公司,目标是向世界新兴经济体提供产品。BioMedica创建于1999年,总部位于新斯高沙省温莎,专长为小型诊所和医院提供心血管诊断和价廉物美的医疗诊断解决方案。BioMedica提供完整的配套便携式仪器、诊断化学药品、实验室器具和配件,便于使用。产品包括血液化学试剂套件、尿液分析测试条、HIV测试和监控设备。BioMedica的产品是QuikCoag化学试剂系列, 用于诊断心脏病等疾病。公司创始人兼*执行长Abdullah Kirumira博士经常因向资源有限的国家提供医药的独*献而受到表彰。 zui近获得世界经济论坛颁发的2009年新兴经济体价廉物美医疗诊断技术开创奖。
http://www.biomedica.co.at/

 

上海金畔生物科技有限公司
实验试剂一站式采购服务商
1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。
2:产品种类齐全,经营超过700多个品牌,基本涵盖所有生物实验试剂耗材。
3:提供加急服务,货品一般1-2周到货。
4:富有竞争力的价格优势,绝大部分价格有优势。
5:多年积累良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等药企。
6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司代理。
7:我们还是invitrogen,qiagen,abcam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等*批发,欢迎合作。

 

 

biomedica 838说明书

biomedica 838说明书

biomedica 838说明书

品牌:biomedica

货号:838

ACTICHROME® AT III ACTIVITY ASSAY

ACTICHROME®ATIII活性测定

    SKU:838 类别:FDA 510(k)清除,所有产品,特殊凝血,血栓风险标记物 标签:Specialty Coagulation Reagents,THROMBOTIC RISK MARKERS

     

     

    产品描述

    测定人血浆中抗凝血酶III活性的显色测定法。

    抗凝血酶III是血浆丝氨酸蛋白酶的抑制剂。抗凝血酶III的重要功能是抑制凝血酶活性。通常,抗凝血酶III对凝血酶的抑制率很慢; 然而,在肝素存在下,该比率可以增加数千倍。

    该测定是两阶段方法,其中将凝血酶加入用过量肝素稀释的血浆中。在初始孵育阶段后,通过添加凝血酶特异性生色底物SPECTROZYME TH来确定残留的凝血酶活性。残留的凝血酶活性与抗凝血酶III浓度成反比。

    产品名称 REF 测试数量
    ACTICHROME ® AT III活性测定 838

    60

     

    ACTICHROME® AT III activity assay

    Category: Coagulation

    Tag: Specialty Coagulation Reagents

     

    ACTICHROME® Heparin (anti-FIIa) assay

    Category: Coagulation

    Tag: Specialty Coagulation Reagents

     

    ACTICHROME® Heparin (anti-FXa) assay

    Category: Coagulation

    Tag: Specialty Coagulation Reagents

     

    ACTICHROME® PLG activity assay

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    ACTICHROME® TF activity assay

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    ACTICHROME® TFPI activity assay

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    ACTICLOT® C, Protein C activity assay

    Category: Coagulation

    Tag: Specialty Coagulation Reagents

     

    ACTICLOT® dPT™, dilute Prothrombin Time test

    Category: Coagulation

    Tag: Specialty Coagulation Reagents

     

    ACTICLOT® Protein C Resistance

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    ACTICLOT® Protein C Resistance, Control Plasmas

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    ACTICLOT® Protein S activity assay

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    ACTIFLUOR™ ADAMTS13 Activity Assay (Outside U.S.A.)

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    ACTIFLUOR™ ADAMTS13 Activity Assay (U.S.A.)

    Category: Coagulation
    Tag: Research Products

     

    ActiScreen™ XL-FDP Latex Agglutination

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    Alpha-Thrombin, human

    Category: Coagulation
    Tag: Research Products

     

    Antithrombin III Deficient Human Plasma

    Category: Coagulation
    Tag: Research Products

     

    Aprotinin

    Category: Coagulation
    Tag: Research Products

     

    DIMERTEST® Latex Kit

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    DVVconfirm®

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    DVVtest®

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    Factor IXa, human, beta sub-unit

    Category: Coagulation
    Tag: Research Products

     

    Factor Va, human

    Category: Coagulation
    Tag: Research Products

     

    Factor VIII deficient human plasma

    Category: Coagulation
    Tag: Research Products

     

    Factor X, human

    Category: Coagulation
    Tag: Research Products

     

    Factor Xa, human, RVV activated

    Category: Coagulation
    Tag: Research Products

     

    Factor XIa, human

    Category: Coagulation
    Tag: Research Products/

    Factor XIIa (activated Hageman Factor)

    Category: Coagulation
    Tag: Research Products

     

    FEMTELLE™ uPA/PAI-1 ELISA (Outside U.S.A.)

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    glu-Plasminogen, human

    Category: Coagulation
    Tag: Research Products

    Goat anti-human Tissue Factor IgG

    Category: Coagulation
    Tag: Research Products

     

    Human glu-plasminogen

    Category: Coagulation
    Tag: Research Products

     

    IMUBIND® ADAMTS13 Autoantibody ELISA (Outside U.S.A.)

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUBIND® ADAMTS13 Autoantibody ELISA (U.S.A.)

    Category: Coagulation
    Tag: Research Products

    IMUBIND® ADAMTS13 ELISA (Outside U.S.A.)

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUBIND® ADAMTS13 ELISA (U.S.A.)

    Category: Coagulation
    Tag: Research Products

     

    IMUBIND® FVIIa ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUBIND® Plasma PAI-1 ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUBIND® Thrombomodulin ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUBIND® Tissue Factor ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUBIND® Tissue PAI-1 ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUBIND® uPA ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUBIND® vWF Activity ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUBIND® vWF ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUCLONE™ Alpha-2-Antiplasmin ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUCLONE™ D-dimer ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUCLONE™ FPA (Fibrinopeptide A) ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUCLONE™ Free Protein S ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    IMUCLONE™ Platelet Factor 4 ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents/

    IMUCLONE™ TAFI ELISA

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    Kallikrein, human

    Category: Coagulation
    Tag: Research Products

     

    LAtrol™ LA Abnormal Control Plasma

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

    LAtrol™ LA Normal Control Plasma

    Category: Coagulation
    Tag: Specialty Coagulation Reagents/

    Murine MAb against fibrin neotope beta-chain IgG

    Category: Coagulation
    Tag: Research Products

     

    Murine MAb against Gla (gamma-carboxyglutamyl) amino acid

    Category: Coagulation
    Tag: Research Products

     

    Murine MAb against human factor VIII-CAg, IgG2a

    Category: Coagulation
    Tag: Research Products

     

    Murine MAb against human fVIIa

    Category: Coagulation
    Tag: Research Products

     

    Murine MAb against human Growth Hormone Receptor

    Category: Coagulation
    Tag: Research Products

     

    Murine MAb against human PAI-1, IgG1

    Category: Coagulation
    Tag: Research Products

     

    Murine MAb against human Tissue Factor

    Category: Coagulation
    Tag: Research Products

     

    Murine MAb against human Tissue Factor, aa 1-25

    Category: Coagulation
    Tag: Research Products

    Murine MAb against human tissue factor, FITC conjugated

    Category: Coagulation
    Tag: Research Products

     

    Murine MAb against human tissue factor, FITC conjugated

    Category: Coagulation
    Tag: Research Products

     

    Plasmin, human

    Category: Coagulation
    Tag: Research Products

     

    Plasminogen activator, u-PAU

    Category: Coagulation
    Tag: Research Products

    Plasminogen, bovine

    Category: Coagulation
    Tag: Research Products

     

    Protac®, direct protein C activator

    Category: Coagulation
    Tag: Research Products

     

    QuikCoag APTT-EA

    Category: Bleeding Profiles

    Tag: Research Products

     

    QuikCoag APTT-S

    Category: Bleeding Profiles

     

    QuikCoag Calcium Chloride 0.020M

    Category: Bleeding Profiles

     

    QuikCoag Control

    Category: Bleeding Profiles

     

    QuikCoag Fibrinogen

    Category: Bleeding Profiles

     

    QuikCoag Fibrinogen Kit

    Category: Bleeding Profiles

     

    QuikCoag Imidazole Buffer

    Category: Bleeding Profiles

     

    QuikCoag Multi Parameter Controls

    Category: Bleeding Profiles

     

    QuikCoag PT-HS

    Category: Bleeding Profiles

     

    Rabbit anti-mouse tissue factor IgG

    Category: Coagulation
    Tag: Research Products

     

    Recombinant factor VIIa, human

    Category: Coagulation
    Tag: Research Products

     

    Recombinant human Tissue Factor

    Category: Coagulation
    Tag: Research Products

     

    Recombinant Thrombomodulin, human

    Category: Coagulation
    Tag: Research Products

    SPECTROFLUOR™ FIXa

    Category: Coagulation
    Tag: Research Products

     

    SPECTROFLUOR™ FXa

    Category: Coagulation
    Tag: Research Products

     

    SPECTROLYSE® PAI-1 Activity Assay

    Category: Coagulation
    Tag: Specialty Coagulation Reagents

     

    SPECTROZYME® FIXa

    Category: Coagulation
    Tag: Research Products

     

    SPECTROZYME® FXa

    Category: Coagulation
    Tag: Research Products

     

    SPECTROZYME® LAL

    Category: Coagulation
    Tag: Research Products

     

    SPECTROZYME® PCa

    Category: Coagulation
    Tag: Research Products

     

    SPECTROZYME® PL

    Category: Coagulation
    Tag: Research Products

     

    SPECTROZYME® TH

    Category: Coagulation
    Tag: Research Products

     

    SPECTROZYME® tPA

    Category: Coagulation
    Tag: Research Products

     

    TFPI Depleted Plasma

    Category: Coagulation
    Tag: Research Products

     

    Thrombomodulin, rabbit lung

    Category: Coagulation
    Tag: Research Products

     

    tPA/PAI Depleted Plasma, human

    Category: Coagulation
    Tag: Research Products

     

    von Willebrand Factor (vWF), human, fVIII free

    Category: Coagulation
    Tag: Research Products

     

    biomedicadiagnostics中国代理, biomedicadiagnostics上海代理, biomedicadiagnostics北京代理,biomedicadiagnostics广东代理, biomedicadiagnostics江苏代理biomedicadiagnostics湖北代理,biomedicadiagnostics天津代理, biomedicadiagnostics黑龙江代理, biomedicadiagnostics内蒙古代理, biomedicadiagnostics吉林代理, biomedicadiagnostics福建代理,  biomedicadiagnostics江苏代理, biomedicadiagnostics浙江代理,  biomedicadiagnostics四川代理,

     

    上海金畔生物科技有限公司是实验试剂一站式采购服务商

    1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。

    2:产品种类齐全,经营超过700多品牌,基本涵盖所有生物实验试剂耗材。

    3:提供加急服务,货品一般1-2周到货。

    4:富有竞争良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等知药企。

    6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司代理。

    7:我们还是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等知*批发,欢迎合作。

     

    3H Biomedica SC0973说明书

    3hbiomedical   3H Biomedical AB

    瑞典三生细胞生物科技有限公司(3H Biomedical AB)为顾客提供的血液细胞及其相关产品均为高质量,来源可靠的生命科学产品。采集过程均由受过专业训练经验丰富的技术人员执行操作,每一环节都符合瑞典国家血液采集法律规定。科学家亦可参照供血者的年龄,性别有针对性的选择产品。供血者均为志愿义务献血。各正常成年捐血者均经过健康测试,包括艾滋病检测(HIV test),乙型肝炎检测(Hepatitis B test)和丙型肝炎检测(Hepatitis C test)。

     

    细胞转染

    在这里你可以找到  转染试剂盒,用于内皮细胞,成纤维细胞,上皮细胞,间充质干细胞,星形胶质细胞,平滑肌细胞和角质形成细胞的转染。

    将外源DNA递送到真核细胞中是研究生物机制的常见的分子生物学技术之一。然而,与转化细胞系不同,原代细胞的有效转染可能是个问题。EndoFectagen是一种基于阳离子聚合物的转染系统,专门设计和优化用于有效转染原代内皮细胞。代替正常的两天转染,可以进行优化的一天转染程序以节省时间和高度可重复的转染。

    EndoFectagen(EndoF)

    细胞转染

    SC0903

     

    EndoFectagen(EndoF)

    细胞转染

    EndoFectagen是一种基于阳离子聚合物的转染系统,专门设计和优化用于有效转染原代内皮细胞。EndoFectagen的转染可以在抗生素和血清的存在下进行。代替正常的两天转染,可以进行优化的一天转染程序以节省时间和高度可重复的转染。在96孔板中,1ml EndoFectagen试剂足以在每孔中进行多达250次转染。(SC0903)(SC0903)

    描述

    储存/处理:收到后,将-20分钟的EndoFectagen试剂A等分并储存,避免反复冻融。解冻后,将EndoFectagen试剂A储存在4°C并在一个月内使用。EndoFectagen试剂B可保持在4°C。

    质量控制:每批EndoFectagen都通过用Promega®ρSV-bata-Galactosidase对照载体转染人脐带血管内皮细胞(HUVEC,目录号SC8000)进行性能测试。转染后24小时通过X-gal染色测定基因表达。通常,可以实现30-60%的转染效率。

     

     

     

    FibroFectagen(FibroF)

    细胞转染

    SC0913

     

    FibroFectagen(FibroF)

    细胞转染

    FibroFectagen是一种基于阳离子聚合物的转染系统,专为原代成纤维细胞的有效转染而设计和优化。FibroFectagen的转染可以在抗生素和血清的存在下进行。代替正常的两天转染,可以进行优化的一天转染程序以节省时间和高度可重复的转染。在96孔板中,1ml FibroFectagen试剂足以在每孔中进行多达200次转染。(SC0913)(SC0913)

    描述

    储存/处理:收到后,在-20°C下等分并储存FibroFectagen试剂A,避免反复冻融。解冻后,将FibroFectagen试剂A保存在4°C并在一个月内使用。FibroFectagen试剂B可保持在4°C。

    质量控制:每批FibroFectagen都通过用Promega®ρSV-bata-Galactosidase控制载体转染人肺成纤维细胞(HPF,Cat.No.SC3300,ScienCell™)进行性能测试。转染后24小时通过X-gal染色测定基因表达。通常,可以实现40-70%的转染效率。

     

     

     

    EpiFectagen(EpiF)

    细胞转染

    SC0923

     

    EpiFectagen(EpiF)

    细胞转染

    将外源DNA递送到真核细胞中是研究生物机制的常见的分子生物学技术之一。然而,与转化细胞系不同,原代细胞的有效转染可能是个问题。EpiFectagen是一种基于阳离子聚合物的转染系统,专为原代上皮细胞的有效转染而设计和优化。用EpiFectagen转染可在抗生素和血清存在下进行。代替正常的两天转染,可以进行优化的一天转染程序以节省时间和高度可重复的转染。在96孔板中,1.5ml EpiFectagen试剂足以在每孔中进行多达100次转染。(SC0923)(SC0923)

     

    描述

    储存/处理:收到后,将Ep​​iFectagen试剂A等分并储存在-20°C,避免反复冻融。解冻后,将Ep​​iFectagen试剂A储存在4°C并在一个月内使用。EpiFectagen试剂B可保持在4°C。

    质量控制:每批EpiFectagen都通过用Promega®ρSV-bata-Galactosidase对照载体转染人肾近端肾小管上皮细胞(HRPTEpiCs,目录号SC4100)进行性能测试。转染后24小时通过X-gal染色测定基因表达。通常,可以实现30-60%的转染效率。

     

     

     

    MesenFectagen

    细胞转染

    SC0933

     

    MesenFectagen

    细胞转染

    将外源DNA递送到真核细胞中是研究生物机制的常见的分子生物学技术之一。然而,与转化细胞系不同,原代细胞的有效转染可能是个问题。MesenFectagen是一种基于阳离子聚合物的转染系统,专门设计和优化用于原代间充质干细胞的有效转染。MesenFectagen的转染可以在抗生素和血清的存在下进行。代替正常的两天转染,可以进行优化的一天转染程序以节省时间和高度可重复的转染。在96孔板中,1ml MesenFectagen试剂足以在每孔中进行多达250次转染。(SC0933)

     

    描述

    储存/处理:收到后,将MesenFectagen试剂A等分并储存在-20°C,避免反复冻融。解冻后,将MesenFectagen试剂A储存在4°C并在一个月内使用。MesenFectagen试剂B可保持在4°C。

    质量控制:每批MesenFectagen都通过用Promega®ρSV-bata-Galactosidase对照载体转染人间充质干细胞(HMSC,目录号SC7500,ScienCell™)进行性能测试。转染后24小时通过X-gal染色测定基因表达。通常,可以实现20-35%的转染效率。

     

     

     

    AstroFectagen(AstroF)

    细胞转染

    SC0943

     

    AstroFectagen(AstroF)

    细胞转染

    AstroFectagen是一种基于阳离子聚合物的转染系统,专为原代星形胶质细胞的有效转染而设计和优化。AstroFectagen的转染可以在抗生素和血清的存在下进行。代替正常的两天转染,可以进行优化的一天转染程序以节省时间和高度可重复的转染。在96孔板中,1ml AstroFectagen试剂足以在每孔中进行多达250次转染。(SC0943)(SC0943)

    描述

    储存/处理:收到后,在-20°C下等分并储存AstroFectagen试剂A,避免反复冻融。解冻后,将AstroFectagen试剂A储存在4°C并在一个月内使用。AstroFectagen试剂B可保持在4°C。

    质量控制:每批AstroFectagen都通过用Promega®ρSV-bata-Galactosidase控制载体转染人类星形胶质细胞(HAs,目录号SC1800)进行性能测试。转染后24小时通过X-gal染色测定基因表达。通常,可以实现20-45%的转染效率。

     

    SMCFectagen(SMCF)

    细胞转染

    SC0953

     

    SMCFectagen(SMCF)

    细胞转染

    SMCFectagen是一种基于阳离子聚合物的转染系统,专门设计和优化用于有效转染原代平滑肌细胞。SMCFectagen的转染可以在抗生素和血清的存在下进行。代替正常的两天转染,可以进行优化的一天转染程序以节省时间和高度可重复的转染。在96孔板中,1.25ml SMCFectagen试剂足以在每孔中进行多达250次转染。(SC0953)(SC0953)

    描述

    储存/处理:收到后,在-20°C下等分并储存SMCFectagen试剂A,避免反复冻融循环。解冻后,将SMCFectagen试剂A储存在4°C并在一个月内使用。SMCFectagen试剂B可保持在4℃。

    质量控制:每批SMCFectagen都通过用Promega®ρSV-bata-Galactosidase控制载体转染人主动脉平滑肌细胞(HASMC,目录号SC6110)进行性能测试。转染后24小时通过X-gal染色测定基因表达。通常,可以实现20-40%的转染效率。

     

     

     

    Kerafectagen(KeraF)

    细胞转染

    SC0963

     

    Kerafectagen(KeraF)

    细胞转染

    KeraFectagen是一种基于阳离子聚合物的转染系统,专为原代角质形成细胞的有效转染而设计和优化。用KeraFectagen转染可在抗生素和血清存在下进行。代替正常的两天转染,可以进行优化的一天转染程序以节省时间和高度可重复的转染。在96孔板中,1.25ml的KeraFectagen试剂足以在每孔中进行多达250次转染。(SC0963)(SC0963)

    描述

    储存/处理:收到后,在-20°C下等分并储存KeraFectagen试剂A,避免反复冻融。解冻后,将KeraFectagen试剂A保存在4°C并在一个月内使用。KeraFectagen试剂B可保持在4°C。

    质量控制:每批KeraFectagen都通过用Promega®ρSV-bata-Galactosidase控制载体转染人表皮角质形成细胞(HEK,目录号SC2100)进行性能测试。转染后24小时通过X-gal染色测定基因表达。通常,可以实现40-60%的转染效率。

     

     

     

    EpiFectagen II(EpiF)

    细胞转染

    SC0973

    EpiFectagen II(EpiF)

    细胞转染

    EpiFectagen II是一种基于阳离子聚合物的转染系统,专门设计和优化用于有效转染在无血清培养基中培养的原代上皮细胞,如人食道上皮细胞,支气管上皮细胞,气管上皮细胞,小气道上皮细胞,前列腺上皮细胞。细胞,角膜上皮细胞,卵巢表面上皮细胞和乳腺上皮细胞。用EpiFectagen II转染可以在抗生素存在下进行。代替正常的两天转染,可以进行优化的一天转染程序以节省时间和高度可重复的转染。(SC0973)(SC0973)

    描述

    储存/处理:收到后,将Ep​​iFectagen II试剂A等分并储存在-20°C,避免反复冻融。解冻后,将Ep​​iFectagen II试剂A储存在2-8°C并在一个月内使用。EpiFectagen II试剂B可保持在2-8°C。

    质量控制:每批EpiFectagen II都通过用Promega®ρSV-bata-Galactosidase对照载体转染人前列腺上皮细胞(HPEpiCs,目录号SC4410)进行性能测试。转染后24小时通过X-gal染色测定基因表达。通常,可以实现~10%的转染效率。

     

    Human Primary Cells/人原代细胞

    1. Peripheral Blood Cell System 外周血细胞系统
    1.1 Human Peripheral Blood Mononuclear Cells/人外周血单核细胞
    1.2 Human Peripheral Blood Pan-T Cells/人外周血Pan-T 细胞
    1.3 Human Peripheral Blood CD4 T Cells/人外周血CD4 T 细胞
    1.4 Human Peripheral Blood CD8 T Cells/人外周血CD8 T 细胞
    1.5 Human Peripheral Blood B Lymphocytes/人外周血B 淋巴细胞
    1.6 Human Peripheral Blood Natural Killer Cells/人外周血自然杀伤细胞
    1.7 Human Peripheral Blood CD14 Monocytes/人外周血CD14 单核细胞
    1.8 Human Monocyte-derived Macrophages/人单核细胞-衍生巨噬细胞
    1.9 Human Peripheral Blood CD34 Stem Cells/人外周血CD34 干细胞
    1.10 Human Peripheral Blood Monocyte-derived Immature Dendritic Cells/人外周血单核细胞-衍生未成熟树突细胞
    1.11 Human Peripheral Blood Plasmacytoid Dendritic Cells/人外周血浆样树突细胞
    1.12 Human Peripheral Blood Myeloid Dendritic Cells/人外周血髓样树突细胞
    1.13 Human Peripheral Blood Endothelial Progenitor Cells /人外周血内皮祖细胞
    1.14 Human Peripheral Blood Eosinophils/人外周血嗜酸性粒细胞
    1.15 Human Peripheral Blood Basophils/人外周血嗜碱性粒细胞
    1.16 Human Peripheral Blood Neutrophils/人外周血嗜中性白细胞
    1.17 Human Peripheral Blood Platelets/人外周血血小板

    2. Umbilical Cord Blood Cell System /脐带血细胞系统
    2.1 Human Umbilical Cord Blood Mononuclear Cells/人脐带血单核细胞
    2.2 Human Umbilical Cord Blood Pan-T Cells/人脐带血Pan-T 细胞
    2.3 Human Umbilical Cord Blood CD4 T Cells/人脐带血CD4 T 细胞
    2.4 Human Umbilical Cord Blood CD8 T Cells/人脐带血CD8 T 细胞
    2.5 Human Umbilical Cord Blood B Lymphocytes/人脐带血B 淋巴细胞
    2.6 Human Umbilical Cord Blood Natural Killer Cells/人脐带血自然杀伤细胞
    2.7 Human Umbilical Cord Blood CD14 Monocytes/人脐带血CD14 单核细胞
    2.8 Human Umbilical Cord Blood CD34 Stem Cells/人脐带血CD34 干细胞
    2.9 Human Umbilical Cord Blood CD133 Stem Cells/人脐带血CD133 干细胞
    2.10 Human Umbilical Cord Blood Mesenchymal Stem Cells/人脐带血间充质干细胞
    2.11 Human Umbilical Cord Blood Monocyte-derived Immature Dendritic Cells/人脐带血单核细胞-衍生未成熟树突细胞
    2.12 Human Umbilical Cord Blood Plasmacytoid Dendritic Cells/人脐带血浆样树突细胞
    2.13 Human Umbilical Cord Blood Myeloid Dendritic Cells/人脐带血髓样树突细胞
    2.14 Human Umbilical Cord Blood Endothelial Progenitor Cells/人脐带血内皮祖细胞
    2.15 Human Umbilical Cord Blood Eosinophils/人脐带血嗜酸性粒细胞
    2.16 Human Umbilical Cord Blood Basophils/人脐带血嗜碱性粒细胞
    2.17 Human Umbilical Cord Blood Neutrophils/人脐带血嗜中性白细胞

    人脉络丛内皮细胞

    3. Hepatic Cell System/肝细胞系统
    3.1 Fresh Human Hepatocytes /新鲜人肝细胞
    3.2 Frozen Human Hepatocytes/冻存人肝细胞
    3.3 Related Human Hepatic Cell Products/人肝细胞相关产品

    Human Cell Lines/人类细胞株

    4. Human Hepatic Cell Lines/人肝细胞株
    4.1 HepaRG
    4.2 HepaRG 细胞系

    Animal Primary Cells/动物原代细胞

    5. Mouse Cell Systems/小鼠细胞系统
    5.1 Mouse Splenocytes – available from several mouse strains/小鼠脾细胞-多种小鼠类型可供选择
    5.2 Mouse Peripheral Blood Mononuclear Cells – available from several mouse strains/小鼠外周血单核细胞-多种小鼠类型可供选择
    5.3 Mouse CD4 T Cells – available from several mouse strains /小鼠CD4 T 细胞-多种小鼠类型可供选择
    5.4 Mouse CD8 T Cells – available from several mouse strains/小鼠CD8 T 细胞-多种小鼠类型可供选择
    5.5 Mouse B Cells – available from several mouse strains/小鼠B 细胞-多种小鼠类型可供选择
    5.6 Mouse Bone Marrow Cells – available from several mouse strains /小鼠骨髓细胞-多种小鼠类型可供选择
    5.7 Mouse Neutrophils – available from several mouse strains/小鼠中性粒细胞-多种小鼠类型可供选择
    5.8 Fresh Mouse Hepatocytes/新鲜小鼠肝细胞
    5.9 Frozen Mouse Hepatocytes/冻存小鼠肝细胞
    5.10 Related Mouse Hepatic Cell Products/小鼠肝细胞相关产品

    6. Rat Cell Systems/大鼠细胞系统
    6.1 Rat Splenocytes – available from several rat strains/大鼠脾细胞-多种大鼠类型可供选择
    6.2 Rat Peripheral Blood Mononuclear Cells – available from several rat strains/大鼠外周血单核细胞-多种大鼠类型可供选择
    6.3 Rat CD4 T Cells – available from several rat strains/大鼠CD4 T 细胞-多种大鼠类型可供选择
    6.4 Rat CD8 T Cells – available from several rat strains/大鼠CD8 T 细胞-多种大鼠类型可供选择
    6.5 Rat B Cells – available from several rat strains/大鼠B 细胞-多种大鼠类型可供选择
    6.6 Rat Bone Marrow Cells – available from several rat strains/大鼠骨髓细胞-多种大鼠类型可供选择
    6.7 Rat Neutrophils – available from several rat strains/大鼠中性粒细胞-多种大鼠类型可供选择
    6.8 Fresh Sprague Dawley Rat Hepatocytes/新鲜Sprague-Dawley 大鼠肝细胞
    6.9 Frozen Sprague Dawley Rat Hepatocytes/冻存Sprague-Dawley 大鼠肝细胞
    6.10 Related Sprague Dawley Rat Hepatic Cell Products/Sprague-Dawley 大鼠肝细胞相关产品
    6.11 Fresh Wistar Rat Hepatocytes/新鲜Wistar 大鼠肝细胞
    6.12 Frozen Wistar Rat Hepatocytes/冻存Wistar 大鼠肝细胞
    6.13 Related Wistar Rat Hepatic Cell Products/Wistar 大鼠肝细胞相关产品

    7. Dog Cell Systems/狗细胞系统
    7.1 Fresh Beagle Dog Hepatocytes/新鲜比格犬肝细胞
    7.2 Frozen Beagle Dog Hepatocytes/冻存比格犬肝细胞
    7.3 Related Beagle Dog Hepatic Cell Products/比格犬肝细胞相关产品
    7.4 Dog Peripheral Blood Mononuclear Cells/狗外周血单核细胞

    8. Monkey Cell Systems/猴细胞系统
    8.1 Fresh Cynomolgus Monkey Hepatocytes/新鲜食蟹猴肝细胞
    8.2 Frozen Cynomolgus Monkey Hepatocytes/冻存食蟹猴肝细胞
    8.3 Related Cynomolgus Monkey Hepatic Cell Products/食蟹猴肝细胞相关产品
    8.4 Frozen Marmoset Monkey Hepatocytes/冻存绒猴肝细胞
    8.5 Related Marmoset Monkey Hepatic Cell Products /绒猴肝细胞相关产品

    9. Rabbit Cell Systems/兔细胞系统
    9.1 Fresh Rabbit Hepatocytes/新鲜兔肝细胞
    9.2 Frozen Rabbit Hepatocytes/冻存兔肝细胞
    9.3 Related Rabbit Hepatic Cell Products/兔肝细胞相关产品

    10. Pig Cell Systems/猪细胞系统
    10.1 Fresh Minipig Hepatocytes/新鲜小型猪肝细胞
    10.2 Frozen Minipig Hepatocytes/冻存小型猪肝细胞
    10.3 Related Minipig Hepatic Cell Products/小型猪肝细胞相关产品

    11. Guinea Pig Cell Systems/豚鼠细胞系统
    11.1 Frozen Guinea Pig Hepatocytes/冻存豚鼠肝细胞
    11.2 Related Guinea Pig Hepatic Cell Products/豚鼠肝细胞相关产品

    12. Hamster Cell Systems/仓鼠细胞系统
    12.1 Frozen Hamster Hepatocytes/冻存仓鼠肝细胞
    12.2 Related Hamster Hepatic Cell Products/仓鼠肝细胞相关产品

    Culture Medium and Supplements/细胞培养基及添加物

    13.1 Cell Culture Medium (see also under each cell type category/细胞培养基
    13.2 Cell Thawing Media/细胞解冻培养基
    13.3 Cell Freezing Media/细胞冻存培养基
    13.4 Cell Detach Media/细胞脱附培养基
    13.5 Fetal Bovine Serum/胎牛血清
    13.6 Supplements and Reagents/添加物及试剂
    13.7 Balanced Salt Solutions and Water/平衡盐溶液及水

    Cell Culture Model Systems/细胞培养模式系统

    14.1 Human LiverbeadsTM/人肝细胞粒
    14.2 Mouse LiverbeadsTM/小鼠肝细胞粒
    14.3 Rat LiverbeadsTM/大鼠肝细胞粒
    14.4 Dog LiverbeadsTM/狗肝细胞粒
    14.5 Monkey LiverbeadsTM/猴肝细胞粒
    14.6 Pig LiverbeadsTM/猪肝细胞粒
    14.7 Human Hepatocyte Sandwich Culture/人肝细胞夹层胶原三明治培养基
    14.8 Rat Hepatocyte Sandwich Culture/大鼠肝细胞夹层胶原三明治培养基

    Tissue Engineering Systems/组织工程系统

    15.1 Human Liver Slices/人肝切片
    15.2 Rat Liver Slices/大鼠肝切片

    Sera/血清

    16.1 Normal Human Serum/正常人血清
    16.2 Normal Human AB Serum/正常人AB 血清

    Plasma/血浆

    17.1 Normal Human Plasma/正常人血浆
    17.2 Human Nickel Plasma/人镍过敏血浆

     

     

     

     

     

    上海金畔生物科技有限公司是实验试剂一站式采购服务商

    1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。

    2:产品种类齐全,经营超过700多品牌,基本涵盖所有生物实验试剂耗材。

    3:提供加急服务,货品一般1-2周到货。

    4:富有竞争力的价格优势,绝大部分价格有优势。

    5:多年积累良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等知药企。

    6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司代理。

    7:我们还是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等知*批发,欢迎合作。

     

    BioMedica Diagnostics 238L COA


    BioMedica Diagnostics是一家自豪的加拿大公司,专注于为人类和动物健康领域提供定制的经济实惠的诊断解决方案。

    BioMedica Diagnostics 238L 说明书

    SAFETY DATA SHEET

    SECTION 1: Identification of the substance/mixture and of the company/undertaking

    1.1. Product identifier

     

    Trade name or designation of the mixture

    Registration number Synonyms

    Product code Issue date Version number

    SPECTROZYME® TH 50 umole

     

    None.     

    238L

    01-December-2017

    02

     

    Revision date 11-July-2017

    Supersedes date 14-July-2015

    1.2. Relevant identified uses of the substance or mixture and uses advised against

     

    Identified uses

    Uses advised against

    Research use only.

    Use in accordance with supplier's recommendations.

    SECTION 2: Hazards identification

    2.1. Classification of the substance or mixture

    The mixture has been assessed and/or tested for its physical, health and environmental hazards and the following classification applies.

    Classification according to Regulation (EC) 272/2008 as amended

    Health hazards

     

    Skin corrosion/irritation

    Serious eye damage/eye irritation

     

    Specific target organ toxicity – single exposure

    Category 2

    Category 2

     

    Category 3 respiratory tract irritation

    H315 – Causes skin irritation.

    H319 – Causes serious eye irritation.

    H335 – May cause respiratory irritation.

     

    Hazard summary Irritating to eyes, respiratory system and skin.

    2.2. Label elements

    Label according to Regulation (EC) 272/2008 as amended

    Contains: H-D-cyclohexylalanyl-alanyl-arginine-para-nitroanilide diacetate saltt

    Hazard pictograms

     

     

     

    Signal word Warning

     

    Hazard statements

    H315 Causes skin irritation.

    H319 Causes serious eye irritation.

    H335 May cause respiratory irritation.

     

    P261 Avoid breathing dust.

    P264 Wash thoroughly after handling.

    P271 Use only outdoors or in a well-ventilated area.

    P280 Wear protective gloves.

    P280 Wear eye/face protection.

    Response

    P302 + P352 IF ON SKIN: Wash with plenty of water.

    P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.

    P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

    P312 Call a POISON CENTER/doctor if you feel unwell. P332 + P313 If skin irritation occurs: Get medical advice/attention. P337 + P313 If eye irritation persists: Get medical advice/attention.

    P362 + P364 Take off contaminated clothing and wash it before reuse.

    Storage

    P403 + P233 Store in a well-ventilated place. Keep container tightly closed. P405 Store locked up.

    Disposal

    P501 Dispose of contents/container in accordance with local/regional/national/international regulations.

    Supplemental label information None.

    2.3. Other hazards Not a PBT or vPvB substance or mixture.

    SECTION 3: Composition/information on ingredients

     

    Chemical name

    % CAS-No / EC

    No

    REACH Registration No

    INDEX No

    Notes

     

     

     

    H-D-cyclohexylalanyl-alanyl-arginine- para-nitroanilide diacetate saltt

    45 – 65

    None  

     

    Classification: Skin Irrit. 2;H315, Eye Irrit. 2;H319, STOT SE 3;H335

     

     

    Glycine

     

    Classification: 

    20 – 40

    56-40-6  

    200-272-2

     

    Composition comments

    All concentrations are in percent by weight unless ingredient is a gas. Gas concentrations are in percent by volume. The full text for all H-statements is displayed in section 16.

     

    SECTION 4: First aid measures

     

    General information

    Ensure that medical personnel are aware of the material(s) involved, and take precautions to protect themselves. If you feel unwell, seek medical advice (show the label where possible).

     

    4.1. Description of first aid measures

     

    Inhalation Skin contact Eye contact

     

    Ingestion

    4.2. Most important symptoms and effects, both acute and delayed

    4.3. Indication of any immediate medical attention and special treatment needed

    Remove victim to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTRE or doctor/physician if you feel unwell.

    Remove contaminated clothing. Wash with plenty of soap and water. If skin irritation occurs: Get medical advice/attention. Wash contaminated clothing before reuse.

    Do not rub eyes. Immediay flush eyes with plenty of water for at least 15 minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Get medical attention if irritation develops and persists.

    Rinse mouth. Get medical attention if symptoms occur.

    May cause redness and pain. Symptoms of overexposure may be headache, dizziness, tiredness, nausea and vomiting.

     

    Provide general supportive measures and treat symptomatically.

     

    SECTION 5: Firefighting measures

     

    General fire hazards

    5.1. Extinguishing media Suitable extinguishing media

    Unsuitable extinguishing media

    5.2. Special hazards arising from the substance or mixture

    5.3. Advice for firefighters Special protective equipment for firefighters

    Special fire fighting procedures

    No unusual fire or explosion hazards noted. Will burn if involved in a fire.

     

    Water fog. Foam. Dry chemical powder. Carbon dioxide (CO2). Do not use water jet as an extinguisher, as this will spread the fire. During fire, gases hazardous to health may be formed.

     

    Self-contained breathing apparatus and full protective clothing must be worn in case of fire. Use standard firefighting procedures and consider the hazards of other involved materials.

     

    SECTION 6: Accidental release measures

    6.1. Personal precautions, protective equipment and emergency procedures

     

    For non-emergency personnel

     

     

    For emergency responders

     

    6.2. Environmental precautions

    6.3. Methods and material for containment and cleaning up

     

     

     

     

     

    6.4. Reference to other sections

    Keep unnecessary personnel away. Keep people away from and upwind of spill/leak. Wear appropriate protective equipment and clothing during clean-up. Avoid inhalation of dust. Ensure adequate ventilation. Local authorities should be advised if significant spillages cannot be contained.

    Keep unnecessary personnel away. Use personal protection recommended in section 8 of the SDS.

    Avoid discharge into drains, water courses or onto the ground.

    Avoid dispersal of dust in the air (i.e., clearing dust surfaces with compressed air). Collect dust using a vacuum cleaner equipped with HEPA filter. Stop the flow of material, if this is without risk.

     

    Large Spills: Wet down with water and dike for later disposal. Shovel the material into waste container. Following product recovery, flush area with water.

     

    Small Spills: Sweep up or vacuum up spillage and collect in suitable container for disposal. Clean surface thoroughly to remove residual contamination.

    For personal protection, see section 8. For waste disposal, see section 13 of the SDS.

     

    SECTION 7: Handling and storage

     

    7.1. Precautions for safe handling

     

     

    7.2. Conditions for safe storage, including any incompatibilities

    7.3. Specific end use(s)

    Minimise dust generation and accumulation. Provide appropriate exhaust ventilation at places where dust is formed. Avoid breathing dust. Avoid contact with eyes, skin, and clothing. Avoid prolonged exposure. Wear appropriate personal protective equipment. Observe good industrial hygiene practices.

    Store locked up. Store in original tightly closed container. Store in a well-ventilated place. Store away from incompatible materials (see section 10 of the SDS).

     

    Research use only.

     

    SECTION 8: Exposure controls/personal protection

    8.1. Control parameters

     

    Occupational exposure limits Biological limit values

    Recommended monitoring procedures

    No exposure limits noted for ingredient(s).

    No biological exposure limits noted for the ingredient(s). Follow standard monitoring procedures.

     

    Derived no-effect level (DNEL) Not available.

     

    Predicted no effect concentrations (PNECs)

    8.2. Exposure controls

    Not available.

     

    Appropriate engineering controls

    Good general ventilation (typically 10 air changes per hour) should be used. Ventilation rates should be matched to conditions. If applicable, use process enclosures, local exhaust ventilation, or other engineering controls to maintain airborne levels below recommended exposure limits. If exposure limits have not been established, maintain airborne levels to an acceptable level. If engineering measures are not sufficient to maintain concentrations of dust particulates below the OEL (occupational exposure limit), suitable respiratory protection must be worn. If material is ground, cut, or used in any operation which may generate dusts, use appropriate local exhaust ventilation to keep exposures below the recommended exposure limits. Eye wash facilities and emergency shower must be available when handling this product.

     

    Individual protection measures, such as personal protective equipment

     

    General information

     

     

    Eye/face protection Skin protection

    – Hand protection

     

    – Other

    Respiratory protection

     

    Thermal hazards Hygiene measures

     

    Environmental exposure controls

    Use personal protective equipment as required. Personal protection equipment should be chosen according to the CEN standards and in discussion with the supplier of the personal protective equipment.

    Wear safety goggles and a face shield.

     

    Wear appropriate chemical resistant gloves. Suitable gloves can be recommended by the glove supplier.

    Wear appropriate chemical resistant clothing.

    In case of inadequate ventilation or risk of inhalation of dust or fumes, use suitable respiratory equipment.

    Wear appropriate thermal protective clothing, when necessary.

    Always observe good personal hygiene measures, such as washing after handling the material and before eating, drinking, and/or smoking. Routinely wash work clothing and protective equipment to remove contaminants.

    Environmental manager must be informed of all major releases.

     

    SECTION 9: Physical and chemical properties

    9.1. Information on basic physical and chemical properties Appearance

     

    Physical state Form

    Colour Odour

    Solid.

    White powder.

    White.

    Not available.

     

    Odour threshold Not available.

    pH Not available.

    Melting point/freezing point Not available.

     

    Initial boiling point and boiling range

    Not available.

     

    Flash point Not available.

    Evaporation rate Not available.

    Flammability (solid, gas) Not available.

    Upper/lower flammability or explosive limits

     

    Flammability limit – lower (%)

    Flammability limit – upper (%)

    Not available.

     

    Not available.

     

    Vapour pressure Not available.

    Vapour density Not available.

    Relative density Not available.

    Solubility(ies) Soluble in water.

     

    Partition coefficient (n-octanol/water)

    Not available.

     

    Auto-ignition temperature Not available. Decomposition temperature Not available. Viscosity Not available.

     

    Explosive properties Oxidizing properties

    9.2. Other information

    Not available.

    Not available.

    No relevant additional information available.

     

    SECTION 10: Stability and reactivity

     

    10.1. Reactivity

    10.2. Chemical stability

    10.3. Possibility of hazardous reactions

    10.4. Conditions to avoid

    10.5. Incompatible materials

    10.6. Hazardous decomposition products

    The product is stable and non-reactive under normal conditions of use, storage and transport. Material is stable under normal conditions.

    Hazardous polymerisation does not occur.

     

    Contact with incompatible materials. Strong oxidising agents. Strong acids. Carbon monoxide. Carbon dioxide.

     

    SECTION 11: Toxicological information

    General information Occupational exposure to the substance or mixture may cause adverse effects.

    Information on likely routes of exposure

    Inhalation Dust may irritate respiratory system. Prolonged inhalation may be harmful.

    Skin contact Causes skin irritation.

    Eye contact Causes serious eye irritation.

    Ingestion May cause discomfort if swallowed.

    Symptoms Symptoms of overexposure may be headache, dizziness, tiredness, nausea and vomiting. May cause redness and pain.

    11.1. Information on toxicological effects

    Acute toxicity May cause discomfort if swallowed.

     

    Skin corrosion/irritation

    Serious eye damage/eye irritation

    Causes skin irritation. Causes serious eye irritation.

     

    Respiratory sensitisation Not a respiratory sensitiser.

     

    Skin sensitisation Germ cell mutagenicity

    Not a skin sensitiser.

    No data available to indicate product or any components present at greater than 0.1% are mutagenic or genotoxic.

     

    Carcinogenicity Not classifiable as to carcinogenicity to humans.

     

    Reproductive toxicity

    Specific target organ toxicity – single exposure

    Specific target organ toxicity – repeated exposure

    This product is not expected to cause reproductive or developmental effects. May cause respiratory irritation.

     

    Not classified.

     

    Aspiration hazard Not classified.

     

    Mixture versus substance information

    Not available.

     

    Other information No other specific acute or chronic health impact noted.

     

    SECTION 12: Ecological information

    12.1. Toxicity The product is not classified as environmentally hazardous. However, this does not exclude the possibility that large or frequent spills can have a harmful or damaging effect on the environment.

     

    12.2. Persistence and degradability

    12.3. Bioaccumulative potential

    Partition coefficient

    n-octanol/water (log Kow)

    No data is available on the degradability of this product.

     

     

    Not available.

     

    Bioconcentration factor (BCF) Not available.

     

    12.4. Mobility in soil

    12.5. Results of PBT and vPvB assessment

    No data available.

    Not a PBT or vPvB substance or mixture.

     

    12.6. Other adverse effects No other adverse environmental effects (e.g. ozone depletion, photochemical ozone creation potential, endocrine disruption, global warming potential) are expected from this component.

     

    SECTION 13: Disposal considerations

    13.1. Waste treatment methods

     

    Residual waste

     

     

    Contaminated packaging

     

     

    EU waste code

     

    Disposal methods/information

    Dispose of in accordance with local regulations. Empty containers or liners may retain some product residues. This material and its container must be disposed of in a safe manner (see: Disposal instructions).

    Empty containers should be taken to an approved waste handling site for recycling or disposal. Since emptied containers may retain product residue, follow label warnings even after container is emptied.

    The Waste code should be assigned in discussion between the user, the producer and the waste disposal company.

    Collect and reclaim or dispose in sealed containers at licensed waste disposal site. Dispose of contents/container in accordance with local/regional/national/international regulations.

     

    SECTION 14: Transport information

    ADR

    Not regulated as dangerous goods.

    RID

    Not regulated as dangerous goods.

    ADN

    Not regulated as dangerous goods.

    IATA

    Not regulated as dangerous goods.

    IMDG

    Not regulated as dangerous goods.

     

    14.7. Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code

    Not applicable.

     

    SECTION 15: Regulatory information

    15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture EU regulations

    Regulation (EC) 005/2009 on substances that deplete the ozone layer, Annex I and II, as amended

    Not listed.

    Regulation (EC) No 850/2004 On persistent organic pollutants, Annex I as amended

    Not listed.

    Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 1 as amended

    Not listed.

    Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 2 as amended

    Not listed.

    Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex I, part 3 as amended

    Not listed.

    Regulation (EC) No 689/2008 concerning the export and import of dangerous chemicals, Annex V as amended

    Not listed.

    Regulation (EC) No 166/2006 Annex II Pollutant Release and Transfer Registry, as amended

    Not listed.

    Regulation (EC) 907/2006, REACH Article 59(10) Candidate List as currently published by ECHA

    Not listed.

    Authorisations

    Regulation (EC) 907/2006, REACH Annex XIV Substances subject to authorization, as amended

    Not listed.

    Restrictions on use

    Regulation (EC) No1907/2006, REACH Annex XVII Substances subject to restriction on marketing and use as amended

    Not listed.

    Directive 2004/37/EC: on the protection of workers from the risks related to exposure to carcinogens and mutagens at work, as amended

    Not listed.

    Directive 92/85/EEC: on the safety and health of pregnant workers and workers who have recently given birth or are breastfeeding, as amended

    Not listed.

    Other EU regulations

    Directive 2012/18/EU on major accident hazards involving dangerous substances

    Not listed.

     

    Directive 98/24/EC on the protection of the health and safety of workers from the risks related to chemical agents at work

    Not listed.

    Directive 94/33/EC on the protection of young people at work

    Not listed.

     

    Other regulations

     

     

     

     

    National regulations

    15.2. Chemical safety assessment

    The product is classified and labelled in accordance with Regulation (EC) 1272/2008 (CLP Regulation) as amended and respective national laws implementing EC directives. This Safety Data Sheet complies with the requirements of Regulation (EC) 907/2006.

    In the European Union this product is regulated under the In Vitro Diagnostic Medical Devices Directive (98/79/EC).

    Follow national regulation for work with chemical agents. No Chemical Safety Assessment has been carried out.

     

    SECTION 16: Other information

    List of abbreviations

     

     

     

    References

    Information on evaluation method leading to the classification of mixture

    Full text of any H-statements not written out in full under Sections 2 to 15

     

     

    Training information Disclaimer

    DNEL: Derived No-Effect Level.

    PNEC: Predicted No-Effect Concentration.

    IARC Monographs. Overall Evaluation of Carcinogenicity

    The classification for health and environmental hazards is derived by a combination of calculation methods and test data, if available.

     

     

     

    H315 Causes skin irritation.

    H319 Causes serious eye irritation. H335 May cause respiratory irritation.

    Follow training instructions when handling this material.

    The information above is provided in good faith. It is believed to be accurate and represents the best information currently available to us. HOWEVER, WE MAKE NO WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR OF ANY OTHER TYPE, EXPRESSED OR IMPLIED, WITH RESPECT TO PRODUCTS DESCRIBED OR DATA OR INFORMATION PROVIDED, AND WE ASSUME NO LIABILITY RESULTING FROM THE USE OF

    SUCH PRODUCTS, DATA OR INFORMATION. Users should make their own investigations to determine the suitability of the information for their particular purposes, and the user assumes all risk arising from their use of the material. The user is required to comply with all laws and regulations relating to the purchase, use, storage and disposal of the material, and must be familiar with and follow generally accepted safe handling procedures. In no event shall BioMedica Diagnostics be liable for any claims, losses, or damages of any individual or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if BioMedica Diagnostics has been advised of the possibility of such damages.

     

     

    上海金畔生物科技有限公司是实验试剂一站式采购服务商

    1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。

    2:产品种类齐全,经营超过700多个品牌,基本涵盖所有生物实验试剂耗材。

    3:提供加急服务,货品一般1-2周到货。

    4:富有竞争力的价格优势,绝大部分价格有优势。

    5:多年积累良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等药企。

    6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司代理。

    7:我们还是invitrogen,qiagen,MiraiBioam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等*批发,欢迎合作。

    Biomedica产品介绍

    Biomedica产品介绍

    简要描述:Biomedica总部位于奥地利的维也纳,是一家关注心脏病学,心脏外科,肾脏科,骨科,等相关领域用于人和动物的诊断试剂和生命科学产品等领域的专业的经销商。

    详细介绍

    产品咨询

    Biomedica总部位于奥地利的维也纳,是一家关注心脏病学,心脏外科,肾脏科,骨科,等相关领域用于人和动物的诊断试剂和生命科学产品等领域的专业的经销商。

    Biomedica Gruppe is a privay owned group of companies in Central Europe with its headquarters in Vienna, Austria. Founded in 1978 as a local distribution company, Biomedica has gradually established subsidiaries in neighbouring countries, Poland and on the Balkans.

    Our core activities are the distribution of advanced and specialised medical devices in the fields of cardiology, cardiac surgery, nephrology, orthopaedics, intensive care, laboratory diagnostics for human and veterinary applications, and Life Sciences. Based on our IP portfolio and in cooperation with other companies and research institutions, the Austrian IVD research team is developing immunoassays for special applications that are manufactured in a dedicated production unit based in Bratislava.

    Through our local offices we have a strong local sales presence with dedicated technical services, all fully ISO 9001 certified and supported by central marketing and product management. An integrated ERP, central management and controlling combine the efficiency of a multinational organisation with regional presence and customer contact in the local language.

    Biomedica Gruppe is organised in several divisions in order to meet the special requirements of our different customer groups. Through our main office in Austria, we offer suppliers the unique possibility to access 12 different countries, each with their own particular requirements.

    公司:www.biomedica.co.at

    bmgrp/Biomedica Immunoassay2021价格表

    bmgrp/Biomedica Immunoassay2021价格表

     

    Biomedica Immunoassay在几个不同的级别上实现此目标:

    •  

      即用型测定

      我们的试剂盒始终带有所有必要的检测成分以及至少一个对照。

    •  

      真实样品中的生物标志物检测

      我们包括基于血清的标准品,以确保我们的ELISA能准确定量分析物,并优化检测范围以检测真实样品中的生物标志物。

    •  

      根据标准进行验证

      我们根据FDA,ICH和EMEA指南验证我们所有的免疫测定。为了*透明,我们在网站上与您共享我们的方法和结果。

    •  

      合格,经验丰富的客户服务

      我们促进客户服务与实验室工作人员之间的不断交流,因此可以为您解答所有疑问。我们总是很乐意分享我们的知识。

    •  

      灵活性

      利用我们的内部生产设施,我们将与您一起寻找可满足您需求的定制解决方案。

    •  

      服务测量

      我们为我们自己和其他制造商的ELISA,Luminex分析,microRNA分析和聚糖谱分析提供定制的分析测试服务。

     

     

    bmgrp/Biomedica Immunoassay2021价格表

     

    货号 品名 规格 价格 品牌
    BI-20022* MDA-oxLDL ELISA 12 x 8 tests 10200 Biomedica Immunoassay2021
    BI-20032 oLAB ELISA 12 x 8 tests 11900 Biomedica Immunoassay2021
    BI-20082H Big Endothelin ELISA 12 x 8 tests 11500 Biomedica Immunoassay2021
    BI-20403 OPG ELISA 12 x 8 tests 11200 Biomedica Immunoassay2021
    BI-20405 Semaphorin 4D ELISA 12 x 8 tests 13900 Biomedica Immunoassay2021
    BI-20409 total Neuropilin-1 ELISA 12 x 8 tests 12100 Biomedica Immunoassay2021
    BI-20413 DKK-1 ELISA 12 x 8 tests 11500 Biomedica Immunoassay2021
    BI-20433 Periostin ELISA 12 x 8 tests 11700 Biomedica Immunoassay2021
    BI-20433MS Periostin mouse ELISA 12 x 8 tests 11500 Biomedica Immunoassay2021
    BI-20462 free sRANKL ELISA 12 x 8 tests 13700 Biomedica Immunoassay2021
    BI-20472 bioactive Sclerostin ELISA 12 x 8 tests 11600 Biomedica Immunoassay2021
    BI-20492 Sclerostin ELISA 12 x 8 tests 11600 Biomedica Immunoassay2021
    BI-20700 FGF23 (intact) ELISA 12 x 8 tests 13300 Biomedica Immunoassay2021
    BI-20702 FGF23 (C-terminal) ELISA 12 x 8 tests 11500 Biomedica Immunoassay2021
    BI-20742 Endostatin ELISA 12 x 8 tests 12100 Biomedica Immunoassay2021
    BI-20742MR Endostatin mouse/rat ELISA 12 x 8 tests 11800 Biomedica Immunoassay2021
    BI-20812 NT-proCNP ELISA 12 x 8 tests 13500 Biomedica Immunoassay2021
    BI-20852W BNP Fragment EIA 12 x 8 tests 10100 Biomedica Immunoassay2021
    BI-20892 NT-proANP ELISA 12 x 8 tests 11900 Biomedica Immunoassay2021
    BI-21032 Borrelien IgG ELISA 12 x 8 tests 6000 Biomedica Immunoassay2021
    BI-21042 Borrelien IgM ELISA 12 x 8 tests 6000 Biomedica Immunoassay2021
    BI-5000 EZ4U Cell Proliferation Assay 10 x 96 tests 3300 Biomedica Immunoassay2021
    BI-5007 OxyStat ELISA 12 x 8 tests 11600 Biomedica Immunoassay2021
    BI-ANG2 Angiopoietin-2 ELISA 12 x 8 tests 11800 Biomedica Immunoassay2021
    BI-ANG2MR Angiopoietin-2 mouse/rat ELISA 12 x 8 tests 11500 Biomedica Immunoassay2021
    BI-LRG LRG ELISA 12 x 8 tests 13300 Biomedica Immunoassay2021
    BI-RC4D Anti C4d 1 vial 6100 Biomedica Immunoassay2021
    BI-RC4D-Fitc Anti C4d, Fitc 1 vial 8500 Biomedica Immunoassay2021
    BI-VAN1MR Vanin-1 mouse/rat ELISA 12 x 8 tests 11900 Biomedica Immunoassay2021
    BI-VAN1U Vanin-1 urinary ELISA 12 x 8 tests 12500 Biomedica Immunoassay2021
    BI-VEGF VEGF ELISA 12 x 8 tests 11500 Biomedica Immunoassay2021
    SK-1204 NT-proBNP ELISA 12 x 8 tests 10100 Biomedica Immunoassay2021

     

    pingming guige jiage pingpai
    MDA-oxLDL ELISA 12 x 8 tests 10200 Biomedica Immunoassay2021
    oLAB ELISA 12 x 8 tests 11900 Biomedica Immunoassay2021
    Big Endothelin ELISA 12 x 8 tests 11500 Biomedica Immunoassay2021
    OPG ELISA 12 x 8 tests 11200 Biomedica Immunoassay2021
    Semaphorin 4D ELISA 12 x 8 tests 13900 Biomedica Immunoassay2021
    total Neuropilin-1 ELISA 12 x 8 tests 12100 Biomedica Immunoassay2021
    DKK-1 ELISA 12 x 8 tests 11500 Biomedica Immunoassay2021
    Periostin ELISA 12 x 8 tests 11700 Biomedica Immunoassay2021
    Periostin mouse ELISA 12 x 8 tests 11500 Biomedica Immunoassay2021
    free sRANKL ELISA 12 x 8 tests 13700 Biomedica Immunoassay2021
    bioactive Sclerostin ELISA 12 x 8 tests 11600 Biomedica Immunoassay2021
    Sclerostin ELISA 12 x 8 tests 11600 Biomedica Immunoassay2021
    FGF23 (intact) ELISA 12 x 8 tests 13300 Biomedica Immunoassay2021
    FGF23 (C-terminal) ELISA 12 x 8 tests 11500 Biomedica Immunoassay2021
    Endostatin ELISA 12 x 8 tests 12100 Biomedica Immunoassay2021
    Endostatin mouse/rat ELISA 12 x 8 tests 11800 Biomedica Immunoassay2021
    NT-proCNP ELISA 12 x 8 tests 13500 Biomedica Immunoassay2021
    BNP Fragment EIA 12 x 8 tests 10100 Biomedica Immunoassay2021
    NT-proANP ELISA 12 x 8 tests 11900 Biomedica Immunoassay2021
    Borrelien IgG ELISA 12 x 8 tests 6000 Biomedica Immunoassay2021
    Borrelien IgM ELISA 12 x 8 tests 6000 Biomedica Immunoassay2021
    EZ4U Cell Proliferation Assay 10 x 96 tests 3300 Biomedica Immunoassay2021
    OxyStat ELISA 12 x 8 tests 11600 Biomedica Immunoassay2021
    Angiopoietin-2 ELISA 12 x 8 tests 11800 Biomedica Immunoassay2021
    Angiopoietin-2 mouse/rat ELISA 12 x 8 tests 11500 Biomedica Immunoassay2021
    LRG ELISA 12 x 8 tests 13300 Biomedica Immunoassay2021
    Anti C4d 1 vial 6100 Biomedica Immunoassay2021
    Anti C4d, Fitc 1 vial 8500 Biomedica Immunoassay2021
    Vanin-1 mouse/rat ELISA 12 x 8 tests 11900 Biomedica Immunoassay2021
    Vanin-1 urinary ELISA 12 x 8 tests 12500 Biomedica Immunoassay2021
    VEGF ELISA 12 x 8 tests 11500 Biomedica Immunoassay2021
    NT-proBNP ELISA 12 x 8 tests 10100 Biomedica Immunoassay2021

     

     

    Biomedica品牌代理

    Biomedica

    简要描述:

    海斯特生物科技有限公司是免疫研究试剂制造商,拥有20多年的经验。他们特别关注产品ELISA试剂盒、抗体和蛋白质等等。

    海斯特生物科技有限公司是免疫研究试剂制造商,拥有20多年的经验。他们特别关注产品ELISA试剂盒、抗体和蛋白质等等。


    With 12 offices in Central and Eastern Europe (CEE) and a team of 250 professionals, Biomedica is a leading distributor of medical devices, in-vitro diagnostics, products for life sciences, Biomedica Immunoassays and Clinical IT. Founded in Vienna more than 35 years ago, we have grown into a multi-national company, still privately held with the main shareholders involved as full-time executives.


    品牌

    货号

    名称

    规格

    Biomedica

    BI-20413

    Dickkopf-1 (DKK-1) ELISA

     12×8-well strips

    Biomedica

    BI-20702

    C-terminal FGF23 ELISA 

     12×8-well strips

    Biomedica

    BI-20462

    FREE soluble RANKL ELISA

    12×8-well strips

    Biomedica

    BI-20403

    Osteoprotegerin ELISA

    12×8-well strips

    Biomedica

    BI-20433

    Periostin ELISA, human

    12×8-well strips

    Biomedica

    BI-20472

    bioactive Sclerostin ELISA

     12×8-well strips